2014
DOI: 10.1007/s00192-014-2450-6
|View full text |Cite
|
Sign up to set email alerts
|

The prevalence of microscopic hematuria in a cohort of women with pelvic organ prolapse

Abstract: This is the largest study to investigate MH in women with prolapse based on the new guidelines. The prevalence of MH was 20.1 % in our study population. Cystoscopy, renal function testing, and CT urography are now recommended after one positive urinalysis, regardless of gender or the presence of prolapse. Owing to the low incidence of urological malignancy detected as well as the increased prevalence of MH found in women with prolapse, specific guidelines for the management of MH in this population are needed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0
3

Year Published

2015
2015
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(12 citation statements)
references
References 16 publications
0
7
0
3
Order By: Relevance
“…Although additional studies are needed in order to assess if it is safe to forego AMH evaluations in postmenopausal women with vaginal atrophy, clinicians should perform and document a genitourinary exam to determine if treatment of vaginal atrophy is necessary. Additionally, the higher presence of AMH (up to 20.1%) 6,12,13 in women with pelvic organ prolapse, compared to the general population, despite a low risk of malignancy, has been used as an argument for separate AMH guidelines for women. Our particular population had a low rate of pelvic organ prolapse with only 11.3% of the documented exams with stage 2 or greater prolapse.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although additional studies are needed in order to assess if it is safe to forego AMH evaluations in postmenopausal women with vaginal atrophy, clinicians should perform and document a genitourinary exam to determine if treatment of vaginal atrophy is necessary. Additionally, the higher presence of AMH (up to 20.1%) 6,12,13 in women with pelvic organ prolapse, compared to the general population, despite a low risk of malignancy, has been used as an argument for separate AMH guidelines for women. Our particular population had a low rate of pelvic organ prolapse with only 11.3% of the documented exams with stage 2 or greater prolapse.…”
Section: Discussionmentioning
confidence: 99%
“…6 The AUA guidelines are vague as to how to consider these potentially confounding conditions in postmenopausal women and many clinicians pursue full AMH evaluations even if vaginal prolapse and atrophy are present, possibly leading to unnecessary, expensive testing and undue patient concern.…”
Section: Introductionmentioning
confidence: 99%
“…Increased prevalence of microscopic hematuria among POP (pelvic organ prolapse) patients has been disputed (5,6). POP frequently results in anatomical distortion of the neighbouring organs and loss of normal function.…”
Section: Introductionmentioning
confidence: 99%
“…[45] Significance of microscopic hematuria, especially during early pregnancy, is still unclear, and in some studies, association between the microscopic hematuria and pregnancy complications has been doubtful.…”
Section: Introductionmentioning
confidence: 99%